FDA Adverse Event Injury Summary report: N

HLM TUBING SET W/BIOLINE COATING

MDR report key: 4768425 · Received May 11, 2015

Report

Report Number
8010762-2015-00443
Event Type
Injury
Date Received
May 11, 2015
Report Date
April 17, 2015
Manufacturer
MAQUET CARDIOPULMONARY AG
Product Code
DTZ
PMA / PMN Number
K101153
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

BASED ON THE REPORTED EVENT AND OUR INVESTIGATIONS, THE REPORTED EVENT IS CAUSED BY USE THAT IS BEYOND THE USAGE DESCRIBED IN OUR LABELING AND CLEARED INTENDED USE. THE INSTRUCTIONS FOR USE (IFU) ART. # 70105.2895, COMMON DEVICE NAME: CARDIOHELP SYSTEM US-03) CLEARLY STATE THE FOLLOWING: CHAPTER 1.2: INTENDED USE: "THE CARDIOHELP SYSTEM IN CONFIGURATION WITH THE HLS/HIT SET ADVANCED IS INTENDED TO BE USED WITHIN THE HOSP ENVIRONMENT AND OUTSIDE THE HOSP ENVIRONMENT (FOR PERIODS UP TO SIX HOURS), E.G. FOR INTRA- AND INTER-HOSPITAL TRANSPORT." ADDITIONAL INFO: THE PRODUCT MENTIONED UNDER SECTION D IS A TUBING SET AND THE INCLUDED AFFECTED COMPONENT HAS THE CONTRIBUTING DESIGN FUNCTION OF THE QUADROX-ID WHICH IS REGISTERED UNDER 510(K): K101153.

Description of Event or Problem · 1

DESCRIPTION FROM THE CUSTOMER REPORT: "CUSTOMER STATED THAT AFTER 41 DAYS OF THERAPY THEY WERE SURPRISED TO SEE BLOOD CLOTS IN HLS MODULE. NO PT DEATH OR HARM." (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
308293 HLM TUBING SET W/BIOLINE COATING DTZ MAQUET CARDIOPULMONARY AG BEQ-HLS 7050 USA

Patients

Seq Age Sex Outcome Treatment
1 Other